연구동향 분석

Prognostic significance of viable tumor size measurement in hepatocellular carcinomas after preoperative locoregional treatment

황윤정 이영은 박현진 이양규 이경분 김혜령 2021년

논문상세정보
인용/피인용
' Prognostic significance of viable tumor size measurement in hepatocellular carcinomas after preoperative locoregional treatment' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Necrosis
  • Prognosis
  • hepatocellularcarci-noma
  • neoadjuvant therapy
  • tumor size
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,095 0

0.0%

' Prognostic significance of viable tumor size measurement in hepatocellular carcinomas after preoperative locoregional treatment' 의 참고문헌

  • Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinoma
    Huang WJ [2015]
  • Tumor size drives the prognosis after hepatic resection of solitary hepatocellular carcinoma without vascular invasion
    Shinkawa H [2020]
  • The General Rules for the Study of Primary Liver Cancer
    장재영 [2017]
  • The Clinicopathological and Prognostic Significance of the Gross Classification of Hepatocellular Carcinoma
    이양규 [2018]
  • Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas : a summary of 480 cases
    Becker K [2011]
  • Prognostic significance of new AJCC tumor stage in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy
  • Prognostic relevance of objective response according to EASL criteria and mRECIST criteria in hepatocellular carcinoma patients treated with loco-regional therapies:a literature-based meta-analysis
    Vincenzi B [2015]
  • Practice Guidelines Committee;American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma
    Bruix J [2005]
  • Pathological tumor regression grade classifications in gastrointestinal cancers : role on patients’prognosis
    Fanelli GN [2019]
  • Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC
    Lencioni R [2017]
  • Modified RECIST(mRECIST)assessment for hepatocellular carcinoma
    Lencioni R [2010]
  • Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant
    Cucchetti A [2020]
  • Importance of tumor size at diagnosis as a prognostic factor for hepatocellular carcinoma survival : a population-based study
    Wu G [2018]
  • Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma : Implications on the current AJCC staging system
    Goh BK [2016]
  • Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy
    Pataer A [2012]
  • Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer : implications for response classification
  • Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
    Bray F [2018]
  • Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinoma
    Jiang T [2013]
  • EASL-EORTC clinical practice guidelines : management of hepatocellular carcinoma
  • EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization
    Gillmore R [2011]
  • Diagnosis, staging, and management of hepatocellular carcinoma : 2018 practice guidance by the American Association for the Study of Liver Diseases
    Marrero JA [2018]
  • Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma
    Yau T [2014]
  • Critical evaluation of the American Joint Commission on Cancer(AJCC)8th edition staging system for patients with Hepatocellular Carcinoma(HCC) : a Surveillance, Epidemiology, End Results(SEER)analysis
  • Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma
    Kim BK [2015]
  • Clinico-radio-pathological and molecular features of hepatocellular carcinomas with keratin 19 expression
    Rhee H [2020]
  • Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver
    Bruix J [2001]
  • American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma
    Rizk NP [2007]
  • AJCC cancer staging manual
    Amin MB [2017]
  • A review of hepatocellular carcinoma(HCC)staging systems
  • 8th edition of the AJCC cancer staging manual : pancreas and hepatobiliary cancers
    Chun YS [2018]